US 11976126
Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 11976126 (Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells) held by Inhibrx, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00